What question did this study set out to answer?

This research aims to identify the role of IL-1α in drug resistance to various generations of EGFR inhibitors in head and neck squamous cell carcinoma.

April 5, 2026Cancer Research

IL-1 Alpha Induces Drug Resistance to All Generations of EGFR Inhibitors in HNSCC

View Full Paper

Ask AI

Bookmark

Authors

NINafis Md. IrfanUniversity of Iowa IKIshrat Nourin Khan NKNurgul KoyuncuUniversity of Iowa

Discussion

Member takes

Implication

Investigates IL-1 alpha's role in drug resistance against EGFR inhibitors in head and neck cancer, suggesting a potential therapeutic target.

Key Points

This research aims to identify the role of IL-1α in drug resistance to various generations of EGFR inhibitors in head and neck squamous cell carcinoma.
HNSCC cell lines treated with first to fourth generation EGFR TKIs for 48 hours
Cell viability assessed using MTT assays
Cytokine expression measured by ELISA and Western blot
IL-1 signaling manipulated using neutralizing antibodies and receptor antagonists
All EGFR TKIs triggered IL-1α release in HNSCC cell lines
IL-6 release was also increased, dependent on IL-1α
Overexpression of IL-1α led to resistance against all EGFR TKIs
Erlotinib-resistant cells showed resistance to other EGFR inhibitors

Cite This Study

Irfan et al. (2026) studied this question.

synapsesocial.com/papers/69d1fe07a79560c99a0a471e https://doi.org/10.1158/1538-7445.am2026-7026

View Full Paper

Ask AI

Bookmark

Implication

Investigates IL-1 alpha's role in drug resistance against EGFR inhibitors in head and neck cancer, suggesting a potential therapeutic target.

IL-1 Alpha Induces Drug Resistance to All Generations of EGFR Inhibitors in HNSCC

Discussion

Member takes

Implication

Key Points

Cite This Study

IL-1 Alpha Induces Drug Resistance to All Generations of EGFR Inhibitors in HNSCC

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider